London Cancer Hub commercial expansion
An approved £1 billion commercial life-sciences development at the Sutton cancer-research campus, led by Aviva Capital Partners and Socius. Around one million square feet of laboratories and research space will expand the district. This record covers the commercial parcel under DM2025/00561, rather than the existing Royal Marsden hospital or Institute of Cancer Research.[1][2][3]
Benefits
- Aviva/Socius commercial-development parcel at the Sutton cancer-research campus. Include the approved expansion, rather than all existing Royal Marsden/ICR facilities.